Project Number 5P01AG014930-17 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for The role of mitochondria-glycolysis interface in developing of AD-associated neuronal mitochondrial dysfunctions. Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 10. Metabolism and Bioenergetics a. Mitochondrial Bioenergetics Researcher and Organization Principal Investigator STARKOV, ANATOLY A Principal Investigator First Name ANATOLY A Principal Investigator Last Name STARKOV Awardee Organization WEILL MEDICAL COLL OF CORNELL UNIV Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-13-258: NIA Program Project Applications (P01) FY Overall Cost $546,714 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official WISE, BRADLEY C Related Resources Repository [AlzPED] Behavioral improvement after chronic administration of coenzyme Q10 in P301S transgenic mice. [AlzPED] Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer’s Disease
